Potomac Capital Management, Inc. Evolus, Inc. Transaction History
Potomac Capital Management, Inc.
- $56.8 Million
- Q4 2023
A detailed history of Potomac Capital Management, Inc. transactions in Evolus, Inc. stock. As of the latest transaction made, Potomac Capital Management, Inc. holds 154,847 shares of EOLS stock, worth $1.72 Million. This represents 2.87% of its overall portfolio holdings.
Number of Shares
154,847
Previous 154,847
-0.0%
Holding current value
$1.72 Million
Previous $1.42 Million
15.19%
% of portfolio
2.87%
Previous 1.91%
Shares
6 transactions
Others Institutions Holding EOLS
# of Institutions
168Shares Held
47.8MCall Options Held
130KPut Options Held
51K-
Perceptive Advisors LLC New York, NY5.36MShares$59.4 Million2.27% of portfolio
-
Tang Capital Management LLC San Diego, CA4.85MShares$53.8 Million6.69% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$44.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$35.4 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.82MShares$31.3 Million2.72% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $622M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...